CervoMed annual operating margin
2010
2011
2012
2013
2023
2024
2025
CervoMed's operating margin was −706.22% for fiscal 2025.
View full CervoMed company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −706.22% | −519.05 pp |
| 2024 | 2024-12-31 | −187.18% | −77.83 pp |
| 2023 | 2023-12-31 | −109.35% | +17746.20 pp |
| 2013 | 2013-12-31 | −17,855.55% | −14707.20 pp |
| 2012 | 2012-12-31 | −3,148.34% | −268.41 pp |
| 2011 | 2011-12-31 | −2,879.94% | +16122.67 pp |
| 2010 | 2010-12-31 | −19,002.60% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −95,479.25% | −95144.33 pp |
| Q3 2025 | 2025-09-30 | −2,493.79% | −2215.60 pp |
| Q2 2025 | 2025-06-30 | −376.41% | −285.35 pp |
| Q1 2025 | 2025-03-31 | −276.55% | −166.00 pp |
| Q4 2024 | 2024-12-31 | −334.91% | −235.32 pp |
| Q3 2024 | 2024-09-30 | −278.19% | −102.95 pp |
| Q2 2024 | 2024-06-30 | −91.06% | −19.49 pp |
| Q1 2024 | 2024-03-31 | −110.55% | −9.24 pp |
| Q4 2023 | 2023-12-31 | −99.59% | +11198.62 pp |
| Q3 2023 | 2023-09-30 | −175.25% | +2215.15 pp |
| Q2 2023 | 2023-06-30 | −71.57% | +2318.82 pp |
| Q1 2023 | 2023-03-31 | −101.31% | +1373.01 pp |
| Q2 2013 | 2013-06-30 | −11,298.21% | −9643.43 pp |
| Q3 2012 | 2012-09-30 | −2,390.40% | — |
| Q2 2012 | 2012-06-30 | −2,390.40% | — |
| Q1 2012 | 2012-03-31 | −1,474.33% | — |
| Q3 2011 | 2011-09-30 | −1,654.78% | — |
Over the last five reported fiscal years, CervoMed's operating margin increased from −2,879.94% to −706.22%, a change of +2173.71 percentage points. The latest reported quarter, Q4 2025, shows −95,479.25%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CervoMed filings at SEC.gov ↗